Viewing StudyNCT02728050



Ignite Creation Date: 2024-05-06 @ 8:23 AM
Last Modification Date: 2024-10-26 @ 11:59 AM
Study NCT ID: NCT02728050
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2016-03-14

Brief Title: Filgrastim Cladribine Cytarabine and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: University of Washington
Organization: University of Washington

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-12-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-03
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-04
Completion Date Type: ACTUAL
First Submit Date: 2016-03-14
First Submit QC Date: March 30 2016
Study First Post Date: 2016-04-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2023-06-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-30
Last Update Post Date: 2023-07-05
Last Update Post Date Type: ACTUAL